{"id":"https://openalex.org/W2076450985","doi":"https://doi.org/10.1021/mp500379d","title":"Conjugation Effects on Antibody\u2013Drug Conjugates: Evaluation of Interaction Kinetics in Real Time on Living Cells","display_name":"Conjugation Effects on Antibody\u2013Drug Conjugates: Evaluation of Interaction Kinetics in Real Time on Living Cells","publication_year":2014,"publication_date":"2014-09-24","ids":{"openalex":"https://openalex.org/W2076450985","doi":"https://doi.org/10.1021/mp500379d","mag":"2076450985","pmid":"https://pubmed.ncbi.nlm.nih.gov/25252166"},"language":"en","primary_location":{"id":"doi:10.1021/mp500379d","doi":"https://doi.org/10.1021/mp500379d","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp500379d","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052984671","display_name":"Sina Bondza","orcid":"https://orcid.org/0000-0003-2420-8626","observed_orcids":["https://orcid.org/0000-0003-2420-8626"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sina Bondza","raw_affiliation_strings":["Section of Biomedical Radiation Sciences, Department of Radiology, Oncology and Radiation Science, Rudbeck Laboratory, Uppsala University , SE-751 85 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Biomedical Radiation Sciences, Department of Radiology, Oncology and Radiation Science, Rudbeck Laboratory, Uppsala University , SE-751 85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057519788","display_name":"Jonas Stenberg","orcid":"https://orcid.org/0000-0003-4990-2200","observed_orcids":["https://orcid.org/0000-0003-4990-2200"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jonas Stenberg","raw_affiliation_strings":["Ridgeview Instruments AB, V\u00e4nge, Sweden","Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ridgeview Instruments AB, V\u00e4nge, Sweden","institution_ids":[]},{"raw_affiliation_string":"Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060280323","display_name":"Marika Nestor","orcid":"https://orcid.org/0000-0003-4662-3142","observed_orcids":["https://orcid.org/0000-0003-4662-3142"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Marika Nestor","raw_affiliation_strings":["Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","Section\rof Otolaryngology and Head and Neck Surgery, Department of Surgical\rSciences, Uppsala University, SE-751 85 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Section\rof Otolaryngology and Head and Neck Surgery, Department of Surgical\rSciences, Uppsala University, SE-751 85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005113209","display_name":"Karl Andersson","orcid":"https://orcid.org/0000-0001-9141-9242","observed_orcids":["https://orcid.org/0000-0001-9141-9242"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karl Andersson","raw_affiliation_strings":["Ridgeview Instruments AB, V\u00e4nge, Sweden","Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ridgeview Instruments AB, V\u00e4nge, Sweden","institution_ids":[]},{"raw_affiliation_string":"Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083279208","display_name":"Hanna Bj\u00f6rkelund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Hanna Bj\u00f6rkelund","raw_affiliation_strings":["Ridgeview Instruments AB, V\u00e4nge, Sweden","Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ridgeview Instruments AB, V\u00e4nge, Sweden","institution_ids":[]},{"raw_affiliation_string":"Section\rof Biomedical Radiation Sciences, Department of Radiology, Oncology\rand Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751\r85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Section#R#of Biomedical Radiation Sciences, Department of Radiology, Oncology#R#and Radiation Science, Rudbeck Laboratory, Uppsala University, SE-751#R#85 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083279208"],"corresponding_institution_ids":["https://openalex.org/I123387679"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.986,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.73636168,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"11","first_page":"4154","last_page":"4163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":1.0},{"id":"https://openalex.org/keywords/conjugation-effects","display_name":"conjugation effects","score":0.9200000166893005},{"id":"https://openalex.org/keywords/antigen-antibody-binding-kinetics","display_name":"antibody-antigen binding kinetics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/association-rate","display_name":"association rate","score":0.7369999885559082},{"id":"https://openalex.org/keywords/dissociation-rate","display_name":"dissociation rate","score":1.0},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8330000042915344},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.9079999923706055},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fiba","display_name":"FIBA","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.802086353302002},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7289994955062866},{"id":"https://openalex.org/C152900378","wikidata":"https://www.wikidata.org/wiki/Q7302366","display_name":"Receptor\u2013ligand kinetics","level":3,"score":0.7125836610794067},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7042868733406067},{"id":"https://openalex.org/C148898269","wikidata":"https://www.wikidata.org/wiki/Q1108792","display_name":"Kinetics","level":2,"score":0.6874454021453857},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.6066855192184448},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5865709781646729},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5799171924591064},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5004637241363525},{"id":"https://openalex.org/C2779712033","wikidata":"https://www.wikidata.org/wiki/Q28208841","display_name":"Dissociation rate","level":3,"score":0.4238690435886383},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4173102378845215},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4121530055999756},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.39575639367103577},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35524284839630127},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3519572615623474},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3228853642940521},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25439101457595825},{"id":"https://openalex.org/C102931765","wikidata":"https://www.wikidata.org/wiki/Q189673","display_name":"Dissociation (chemistry)","level":2,"score":0.2157706916332245},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20006483793258667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14986363053321838},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1406668722629547},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018960","descriptor_name":"Hyaluronan Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018960","descriptor_name":"Hyaluronan Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D054730","descriptor_name":"Protein Interaction Domains and Motifs","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp500379d","doi":"https://doi.org/10.1021/mp500379d","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp500379d","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:25252166","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25252166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Evaluation Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W197699128","https://openalex.org/W1493773816","https://openalex.org/W1517685097","https://openalex.org/W1733847523","https://openalex.org/W1968620174","https://openalex.org/W1969808504","https://openalex.org/W1975954510","https://openalex.org/W1977952379","https://openalex.org/W1989837159","https://openalex.org/W1993880825","https://openalex.org/W2001020956","https://openalex.org/W2003198224","https://openalex.org/W2016408686","https://openalex.org/W2022725046","https://openalex.org/W2024108044","https://openalex.org/W2027534581","https://openalex.org/W2033785962","https://openalex.org/W2034609970","https://openalex.org/W2043228552","https://openalex.org/W2052465009","https://openalex.org/W2056055483","https://openalex.org/W2056405796","https://openalex.org/W2059327554","https://openalex.org/W2059530338","https://openalex.org/W2060740491","https://openalex.org/W2069152342","https://openalex.org/W2070727232","https://openalex.org/W2072018486","https://openalex.org/W2074566110","https://openalex.org/W2082178103","https://openalex.org/W2083709832","https://openalex.org/W2092187686","https://openalex.org/W2093963201","https://openalex.org/W2113584131","https://openalex.org/W2119335494","https://openalex.org/W2124101088","https://openalex.org/W2124514746","https://openalex.org/W2126879510","https://openalex.org/W2134342060","https://openalex.org/W2138654358","https://openalex.org/W2152176229","https://openalex.org/W2154912544","https://openalex.org/W2162298868","https://openalex.org/W2167463450","https://openalex.org/W2170132049","https://openalex.org/W2172114959","https://openalex.org/W2327899001","https://openalex.org/W4230483407"],"related_works":["https://openalex.org/W2028791057","https://openalex.org/W2055973049","https://openalex.org/W2997733976","https://openalex.org/W2007756994","https://openalex.org/W4321767505","https://openalex.org/W7110562147","https://openalex.org/W6912982277","https://openalex.org/W2463348911","https://openalex.org/W3034221570","https://openalex.org/W2742206398"],"abstract_inverted_index":{"Antibody-drug":[0],"conjugates":[1],"(ADC)":[2],"have":[3,78],"shown":[4],"promising":[5],"effects":[6,80,109],"in":[7,138],"cancer":[8],"therapy":[9],"by":[10],"combining":[11],"the":[12,19,26,48,59,74,82,85,88,105,117,132,147,152,159,165,181,184,195,204,208,246],"target":[13],"specificity":[14],"of":[15,21,28,50,73,84,107,155,158,178,229],"an":[16,51,55,240,243],"antibody":[17,56,111,162,167,241],"with":[18,61,183],"toxicity":[20],"a":[22,102,121,253,259],"chemotherapeutic":[23],"drug.":[24],"As":[25],"number":[27],"therapeutic":[29,160],"antibodies":[30],"is":[31,40,217],"significantly":[32],"larger":[33],"than":[34],"those":[35],"used":[36,250],"as":[37,215],"ADCs,":[38,86],"there":[39],"unused":[41],"potential":[42],"for":[43,104,211,258],"more":[44,256],"effective":[45],"therapies.":[46],"However,":[47],"conjugation":[49,108,225,233],"additional":[52],"molecule":[53],"to":[54,92,113,206,219,251],"may":[57],"affect":[58,131],"interaction":[60,182,197,230],"its":[62,114],"target,":[63],"altering":[64],"association":[65],"rate,":[66,68],"dissociation":[67],"or":[69,242],"both.":[70],"Any":[71],"changes":[72],"binding":[75,112,153,209,254],"kinetics":[76,89,231],"can":[77,248],"subsequent":[79],"on":[81,110,194],"efficacy":[83],"thus":[87],"are":[90],"important":[91],"monitor":[93],"during":[94],"ADC":[95,213],"development":[96],"and":[97,120,164,172],"production.":[98],"This":[99,202],"paper":[100],"describes":[101],"method":[103,151],"analysis":[106],"antigen,":[115],"using":[116,141],"instrument":[118],"LigandTracer":[119],"fluorescent":[122],"monovalent":[123],"anti-IgG":[124],"binder":[125],"denoted":[126],"FIBA,":[127],"which":[128,144],"did":[129],"not":[130],"interaction.":[133],"All":[134],"measurements":[135],"were":[136,170],"done":[137],"real":[139],"time":[140],"living":[142],"cells":[143],"naturally":[145],"expressed":[146],"antigens.":[148],"With":[149],"this":[150],"profiles":[154],"different":[156],"conjugations":[157,247],"anti-EGFR":[161],"cetuximab":[163,179],"anti-CD44v6":[166],"fragment":[168],"AbD15171":[169],"evaluated":[171],"compared.":[173],"Even":[174],"comparatively":[175],"small":[176],"modifications":[177],"altered":[180],"epidermal":[185],"growth":[186],"factor":[187],"receptor":[188],"(EGFR).":[189],"In":[190],"contrast,":[191],"no":[192],"impact":[193],"AbD15171-CD44v6":[196],"was":[198],"observed":[199],"upon":[200],"conjugation.":[201],"illustrates":[203],"importance":[205],"study":[207],"profile":[210,255],"each":[212],"combination,":[214],"it":[216],"difficult":[218],"draw":[220],"any":[221],"general":[222],"conclusion":[223],"about":[224],"effects.":[226],"The":[227],"modification":[228],"through":[232],"opens":[234],"up":[235],"new":[236],"possibilities":[237],"when":[238],"optimizing":[239],"ADC,":[244],"since":[245],"be":[249],"create":[252],"apt":[257],"specific":[260],"clinical":[261],"need.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}